Suppr超能文献

肾移植受者血清的致有丝分裂抑制和同种抗体活性

Blastogenic suppression and alloantibody activity of sera from renal allograft recipients.

作者信息

Johnson A H, Rossen R D, Hersh E M, Farrow S S, Butler W T, Suki W N

出版信息

J Clin Invest. 1974 Jan;53(1):270-8. doi: 10.1172/JCI107547.

Abstract

To evaluate whether immunological enhancement plays a role in adaptation to renal allografts, we studied sera from transplant recipients to determine whether those which suppressed mixed leukocyte culture (MLC) responses in vitro contained alloantibodies reactive with donor cells. Sera from five of nine renal transplant recipients consistently and specifically suppressed autologous autologous MLC responses to donor cells without impairing the blastogenic responses to third-party leukocytes, soluble antigens, or nonspecific mitogenic agents. In three of the five cases the suppressive activity of the serum was striking; in two cases the effect was less marked but still readily demonstrable in studies designed to evaluate the dose of serum which provided optimal suppression of MLC responses. Serum from one of the recipients nonspecifically suppressed blastogenic activity both to donor cells and other stimuli. No alloantibody reactive with donor leukocytes was found in any of the sera which exhibited suppressive activity in MLC, whereas in one patient, serum which contained antibody reactive with donor cells did not suppress MLC response to that donor. These findings suggest that, if the serum factors which suppress MLC responses in vitro are enhancing antibodies, they are not detectable even with very sensitive techniques either because they are present in very low concentrations, belong to immunoglobulin classes other than IgA, IgG, or IgM, or are complexed with donor antigen in such a way that their ability to react with fresh donor cells in vitro is blocked.

摘要

为了评估免疫增强在肾移植适应过程中是否起作用,我们研究了移植受者的血清,以确定那些在体外抑制混合淋巴细胞培养(MLC)反应的血清中是否含有与供体细胞反应的同种抗体。9名肾移植受者中有5人的血清持续且特异性地抑制了对供体细胞的自体MLC反应,而不损害对第三方白细胞、可溶性抗原或非特异性促有丝分裂剂的增殖反应。在这5例中的3例中,血清的抑制活性显著;在2例中,效果不太明显,但在旨在评估提供MLC反应最佳抑制作用的血清剂量的研究中仍易于证明。其中一名受者的血清非特异性地抑制了对供体细胞和其他刺激的增殖活性。在任何在MLC中表现出抑制活性的血清中均未发现与供体白细胞反应的同种抗体,而在一名患者中,含有与供体细胞反应抗体的血清并未抑制对该供体的MLC反应。这些发现表明,如果在体外抑制MLC反应的血清因子是增强抗体,那么即使使用非常敏感的技术也检测不到它们,这要么是因为它们以极低的浓度存在,属于IgA、IgG或IgM以外的免疫球蛋白类别,要么是以这样一种方式与供体抗原复合,即它们在体外与新鲜供体细胞反应的能力被阻断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d39/301462/3654a9d2e837/jcinvest00157-0282-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验